Swedish start-up receives Series A funding

A two-year old Swedish company with a novel strategy for treating cancer, Axcentua Pharmaceuticals AB, has raised an undisclosed amount of money in a Series A financing round. It will use the funds to bring its lead molecule into the clinic.